Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications

Biomarker-driven cancer therapy has revolutionized precision oncology. With a better understanding of tumor biology, tissue-agnostic targets have been characterized and explored, which ultimately led to therapeutics with pan-cancer efficacy. To date, five molecular biomarkers have obtained FDA tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, Mohamed A., Nelson, Blessie E., Buschhorn, Lars, Wahida, Adam, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390861/
https://www.ncbi.nlm.nih.gov/pubmed/37061987
http://dx.doi.org/10.1158/1078-0432.CCR-23-0090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390861/
https://www.ncbi.nlm.nih.gov/pubmed/37061987
http://dx.doi.org/10.1158/1078-0432.CCR-23-0090

Ejemplares similares